Navigation Links
Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients

PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 12, 2007 - Affymax, Inc. (Nasdaq:AFFY) today announced that results available from its Phase 2 clinical trial of Hematide(TM) dosed monthly in dialysis patients were presented this week at the National Kidney Foundation (NKF) 2007 Spring Clinical Meeting. The results from this maintenance-switch trial in patients previously treated with three-times weekly Epoetin Alfa (EPO) demonstrated that mean hemoglobin (Hgb) levels can be maintained at clinically acceptable levels following a switch to once-monthly treatments with Hematide at an appropriate dosing regimen. The data were presented by Anatole Besarab, M.D., adjunct professor of Medicine, Wayne State University and director of Clinical Research at Henry Ford Hospital, Detroit in a poster session at the NKF meeting.

"These data are encouraging and show that patients can be switched from a regimen of EPO three-times weekly to once monthly Hematide in a controlled fashion where hemoglobin levels were maintained within 1 g/dL of baseline at an appropriate dosing regimen," said Dr. Besarab. This is especially important given the growing concerns related to excessive hemoglobin increases due to erythropoiesis stimulating agent use."

"We believe these data support the once per month dosing of Hematide and warrant further investigation in pivotal clinical studies," added Anne-Marie Duliege, M.D., vice president, Clinical, Medical and Regulatory Affairs at Affymax. "Based on the entire Phase 2 data set and as a result of our end of Phase 2 meetings with the Food and Drug Administration (FDA), we are preparing for Phase 3 clinical trials in patients on dialysis and not on dialysis. We are currently in discussions with the FDA on the design of this Phase 3 program."

The Phase 2 trial, which involved 165 patients, was an open label, multi-dose study conducted to assess safety, pharmacodynamics and pharmacokinetics of
'"/>




Page: 1 2 3

Related medicine technology :

1. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
2. Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:4/24/2015)... NEW YORK , April 24, 2015 /PRNewswire/ ... Diseases (NIAID) (part of the National Institutes of ... million to nine research projects for the development ... light of  recent HAI outbreaks at U.S. health ... are supporting research into rapid, multiplexed and effective ...
(Date:4/24/2015)... , April 24, 2015  Elekta has CE ... Monaco® treatment planning system , enabling European clinics to ... major treatment techniques including advanced 3D planning, IMRT, VMAT ... Monaco ® ... well improved workflow efficiency. Advancements in 3D planning as ...
(Date:4/23/2015)... , April 23, 2015 Once again, BeaconMedaes ... our commitment to patient safety. BeaconMedaes, priority ... against infectious disease. The next generation Zone ... gas sensors are now mounted in the assembly, allowing ... to open ceiling tiles potentially releasing dust spores and ...
Breaking Medicine Technology:Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4Elekta CE marks for Monaco v5.10 treatment planning system 2BeaconMedaes launches new Zone Valve Box Assembly 2
(Date:4/26/2015)... CA (PRWEB) April 26, 2015 In an ... Washington State University evaluated the head-neck biomechanics occurring during the ... the study were able to determine that use of a ... as 3 to 5 times - more than when the ... outcome for such a study, but pointing out the potential ...
(Date:4/26/2015)... TN (PRWEB) April 26, 2015 ... to grow throughout the Southeast. MidSouth Pain Treatment Center ... locations in Cordova, Southaven, Oxford and Jackson, two ambulatory ... laboratory in the Southaven and Cordova locations. , ... ”I went into medicine to help people, and ...
(Date:4/25/2015)... April 26, 2015 Avid Collector Andrew ... 1965 Rolling Stones Greensboro Coliseum concert posters. The concert ... of the Stone's Second American Tour. , According ... Company out of Baltimore, Maryland. This poster blank was ... and southern cites. Globe uses garish lettering and colors ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 In the ... twelve and above needed treatment for an illicit ... the Substance Abuse and Mental Health Services Administration’s Survey ... Beyond these alarming numbers are harrowing stories of men ... substance abuse . David H. Kerr , founder ...
(Date:4/25/2015)... By definition, a CIO’s responsibility is to ... relying on their judgement and expertise to keep digital assets ... an article published in National Mortgage News on April ... a disservice to their responsibilities by focusing too heavily on ... crossed when it comes to company policy and industry best ...
Breaking Medicine News(10 mins):Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5
... - Contract Extended One Year -LEXINGTON, Mass., Jan. ... MedAssets Supply Chain Systems has extended its contract ... 2010. This continues a successful history between ... in 2002.The contract covers IL,s portfolio of critical ...
... Medimetriks Pharmaceuticals announced today that the Company ... (Nasdaq: PRGO ), a leading manufacturer in ... Authorized Distributor of generic versions of Medimetriks, branded products ... to receive a percentage of Perrigo,s Net Sales on ...
... HEIGHTS, N.J., Jan. 26 Authentidate Holding Corp. ... of secure Health Information Exchange and workflow management ... from representatives of Parascript, LLC and Parascript Management, ... Agreement and Plan of Merger it entered into ...
... standards snag company awardIRVINE, Calif., Jan. 26 ... in phytochemical reference standards and contract research, announced ... natural products and alternative health care magazine, selected ... Scientific Achievement Award recipients for its achievement in ...
... 26 Trintech Group Plc (Nasdaq: TTPA ... transaction risk management, and compliance solutions, today announced that ... meet on January 27 in Mountain View, California as ... share common experiences, discuss the latest market trends and ...
... announced,that it has launched the International College ... surgical teams from around the world.,The launch was announced ... San Francisco. , "We have ... we began our program in 2002," says Kirk Wilson, ...
Cached Medicine News:Health News:Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio 2Health News:Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio 3Health News:Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals 2Health News:Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals 3Health News:Authentidate Announces Termination of Merger Agreement With Parascript, LLC 2Health News:Authentidate Announces Termination of Merger Agreement With Parascript, LLC 3Health News:ChromaDex Awarded Nutrition Business Journal Scientific Achievement 2Health News:KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times 2Health News:KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times 3Health News:Saint Joseph's Launches International College of Robotic Surgery 2
... Stereotactic Linking System simplifies planning for complex ... This software integrates multiple patient data ... data, to assist in charting the best ... location. Framelink interfaces seamlessly with the ...
It provides cranial support in either prone or supine positions for premature infants and young children....
Horseshoe shaped headrest that provides cranial support in the prone or supine position for adults and older children....
Bunnel hand drill with Jacobs chuck, chuck size 4 mm....
Medicine Products: